Grifols is a global pharmaceutical company developing, manufacturing and distributing a range of biological medicines based on plasma derived proteins. Co. organizes its business into several divisions, including: Bioscience, which includes activities relating to the manufacture of plasma derivatives for therapeutic use, and the sale and distribution of end products; Diagnostic, which focuses on researching, developing, manufacturing and marketing in vitro diagnostics products; Hospital, which provides technology and services for hospitals, clinics and other centers for the manufacture of medicines; and Bio Supplies, which primarily consists of biological products for non-therapeutic use. When considering the Grifols SA, Barcelona stock dividend history, we have taken known splits into account, such that the GRFS dividend history is presented on a split-adjusted ("apples to apples") basis. Grifols SA, Barcelona dividend history is presented both in graphical/chart form, and as a GRFS dividend history data table along the right-hand column.
|
GRFS Stock Dividend HistoryThe GRFS dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable GRFS historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the GRFS dividend history record. Also see the GRFS stock dividend history data table along the right-hand column below. |
|
|
Hold (2.00 out of 4) 0th percentile
(ranked lower than approx. 100% of all stocks covered)
Analysts' Target Price: GRFS Forecast Based on data provided by Zacks Investment Research via Quandl.com |